Publicacións nas que colabora con Gregory Y.H. Lip (24)

2022

  1. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

    European heart journal, Vol. 43, Núm. 41, pp. 4229-4361

2021

  1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

2018

  1. Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey)

    American Journal of Cardiology, Vol. 122, Núm. 4, pp. 578-583

  2. State of play and future direction with NOACs: An expert consensus

    Vascular Pharmacology, Vol. 106, pp. 9-21

2017

  1. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: The task force for cancer treatments and cardiovascular toxicity of the european society of cardiology (ESC)

    Russian Journal of Cardiology

  2. 2016 ESC/EAS guidelines for the management of dyslipidemias

    Revista Espanola de Cardiologia, Vol. 70, Núm. 2, pp. 115.e-115.e

  3. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

    Journal of the American College of Cardiology, Vol. 69, Núm. 7, pp. 777-785

2016

  1. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, Vol. 50, Núm. 5, pp. e1-e88

  2. Stanowisko ESC dotyczace toksycznego wpływu leczenia onkologicznego na UKład sercowo-naczyniowy w 2016 roku, opracowane pod auspicjami Komisji ESC do spraw Wytycznych Post? Powania Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw toksycznego wpływu leczenia onkologicznego na UKład sercowo-naczyniowy

    Kardiologia Polska, Vol. 74, Núm. 11, pp. 1193-1233

  3. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: Perceptions of 'valvular' atrial fibrillation: Results of the European Heart Rhythm Association Survey

    Europace, Vol. 18, Núm. 10, pp. 1593-1598

2014

  1. Remote monitoring of cardiac implantable electronic devices in Europe: Results of the European Heart Rhythm Association survey

    Europace, Vol. 16, Núm. 1, pp. 129-132

2013

  1. Cardioversion for atrial fibrillation in current European practice: Results of the European Heart Rhythm Association survey

    Europace, Vol. 15, Núm. 6, pp. 915-918

  2. Current practice for diagnosis and management of silent atrial fibrillation: Results of the European Heart Rhythm Association survey

    Europace, Vol. 15, Núm. 8, pp. 1223-1225

2012

  1. Guidelines on the management of valvular heart disease (version 2012)

    European Heart Journal, Vol. 33, Núm. 19, pp. 2451-2496

  2. The joint task force on the management of valvular heart disease of the European Society of cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

    European Journal of Cardio-thoracic Surgery, Vol. 42, Núm. 4, pp. S1-S44

2011

  1. Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: A pilot study

    Thrombosis Research

2010

  1. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The euro heart survey

    Chest, Vol. 138, Núm. 5, pp. 1093-1100

  2. Guidelines for the management of atrial fibrillation

    European Heart Journal, Vol. 31, Núm. 19, pp. 2369-2429

  3. Guidelines for the management of atrial fibrillation

    Europace, Vol. 12, Núm. 10, pp. 1360-1420

  4. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation

    Chest, Vol. 137, Núm. 2, pp. 263-272